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ABSTRACT
Oocytes treated with the protein synthesis inhibitor cyclohex-
imide (CHX) arrest at the germinal vesicle (GV) stage and undergo
accelerated GV breakdown (GVBD) after CHX is removed.
However, little is known about the underlying mechanism of
accelerated meiotic maturation. Here, we investigated this
mechanism and found that oocytes released from CHX arrest have
higher amounts of cyclin B1 (CCNB1) and phosphorylated
mitogen-activated protein kinase (pMAPK) proteins. Increased
levels of these factors were not associated with mRNA polyade-
nylation or increased transcription rates of CCNB1 and MOS
(Moloney murine sarcoma viral oncogene homolog) during CHX
arrest. We found that treatment of CHX-arrested oocytes with the
actin filament-stabilizing agent Jasplakinolide (Jasp)delayedGVBD
following release fromCHXarrest and that thiswas correlatedwith
reduced maturation-promoting factor (MPF) activity. These results
suggest that CCNB1 mRNAs released from actin filaments during
CHX arrest increase CCNB1 transcripts available for translation
after release from CHX arrest, leading to the precocious activation
of MPF and accelerated meiotic progression.
actin depolymerization, cyclin B1, cycloheximide, cytoskeleton,
GVBD, IVM, meiotic arrest, meiotic maturation, oocyte
maturation, polyadenylation, protein kinases, RNA granules
INTRODUCTION
Fully grown, immature mammalian oocytes are arrested at
the germinal vesicle (GV) stage but resume meiosis under the
influence of maturation-promoting factor (MPF) and mitogen-
activated protein kinase (MAPK). MPF is a complex composed
of the regulatory subunit cyclin B1 (CCNB1) and the catalytic
subunit cyclin-dependent kinase 1 (CDK1). With the exception
of rodents, mammalian oocytes must synthesize CCNB1 de
novo to form active MPF when meiosis is resumed. CCNB1
has not been detected in GV bovine [1] and porcine [2]
oocytes, and microinjection of CCNB1 in the absence of
protein synthesis is sufficient to induce GVBD in bovine
oocytes [1]. MAPK, another important factor in meiotic
regulation, is activated by mitogen activated protein kinase
kinase (also known as MEK), which in turn is activated by
MOS (Moloney murine sarcoma viral oncogene homolog).
Whereas MOS production depends on de novo synthesis,
MAPK and MEK are present in GV oocytes, but in an inactive
state. Although MAPK activity within the oocyte is not
required for meiotic resumption in farm animals [3–5], artificial
activation of MAPK induces accelerated GV breakdown
(GVBD) in bovine and porcine oocytes [5, 6] and is sufficient
to induce GVBD in the absence of MPF activity [7–9]. Taken
together, these data indicate that MPF and MAPK are key
molecules regulating GVBD.
Many transcripts in oocytes are accumulated in a dormant
state with short poly(A) tails; key proteins are produced by
activation of these stored transcripts to orchestrate meiotic
progression and early embryo cleavage. Activation of dormant
mRNAs, including CCNB1 and MOS, can be mediated by
polyadenylation of their short poly(A) tails, which are
polyadenylated during mammalian oocyte maturation [10–
14], thus leading to their translation [11, 12, 15].
As well as being regulated by polyadenylation, CCNB1 can
form granules in the cytoplasm of immature mouse and
zebrafish oocytes [16]. In zebrafish, these dormant RNA
granules are disassembled following oocyte maturation to
allow CCNB1 synthesis followed by GVBD, a process
requiring actin depolymerization [16]. These findings suggest
that release of CCNB1 from granules plays an important role in
the timing of CCNB1 translation and subsequent GVBD.
The GV-arrested oocytes undergo cytoplasmic maturation
within the ovary, but they resume meiosis spontaneously when
removed from the inhibitory environment of the follicles. In an
attempt to improve cytoplasmic maturation and enhance
embryo development after in vitro fertilization (IVF), meiotic
inhibitors have been used to prevent resumption of nuclear
maturation of isolated oocytes. Cycloheximide (CHX), a
protein synthesis inhibitor, has been widely used as a meiotic
inhibitor because protein synthesis is critical for oocyte
maturation [17, 18]. Meiotic arrest using CHX can improve
developmental competence of porcine oocytes [19] but not of
bovine oocytes [20–22], although live births have been
reported after 24-h CHX arrest [22]. Interestingly, after CHX
arrest, oocytes undergo accelerated GVBD, a phenomenon
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observed in sheep [17], cattle [23, 24], pigs [25], and goats
[26]. However, the underlying mechanism of accelerated
GVBD following meiotic arrest is unknown.
In the present study, we investigated the mechanism
underlying accelerated meiotic progression in oocytes after
CHX treatment and release from arrest. We hypothesized that
whereas CHX prevents nuclear maturation, it does not prevent
activation of meiotic resumption pathway(s) that may lead to
the accumulation of key factors associated with meiotic
progression in oocytes. We found that meiotic acceleration in
ovine oocytes after release from CHX arrest was correlated
with early accumulation of CCNB1 and increased MAPK
phosphorylation. The mechanism underlying meiotic acceler-
ation was not associated with mRNA polyadenylation or
transcription of CCNB1 or MOS. We show that stabilization of
actin filaments during CHX arrest delays GVBD following
release from arrest by delaying MPF activation, whereas
disruption of actin filaments during arrest enhances the
acceleration of GVBD following release. Our results support
a model of actin depolymerization-mediated release of stored
CCNB1 during CHX arrest that becomes available to the
translational machinery, thus leading to early translation of
CCNB1 and accelerated meiotic progression after CHX
withdrawal in oocytes from ungulates.
MATERIALS AND METHODS
Oocyte Recovery, CHX Treatment, and In Vitro Maturation
of Oocytes
Ovine ovaries were collected from a local slaughter house and transported
to the laboratory within 3 h in warm (30–358C) PBS (160 mM NaCl, 3 mM
KCl, 8 mM Na
2
HPO
4
, and 1 mM KH
2
PO
4
). Medium-sized (2–4 mm) follicles
were aspirated using a needle and syringe. To the treatment group, CHX was
added (final concentration, 5 lg/ml) to the follicular fluid during the aspiration
process. Cumulus-oocyte complexes (COCs) with at least two layers of
cumulus cells were selected for maturation using in vitro maturation (IVM)
medium (bicarbonate-buffered M199 medium [Gibco] supplemented with 10%
heat-inactivated fetal bovine serum [FBS], 0.05 U/ml of follicle-stimulating
hormone/luteinizing hormone [Pluset], 1.0 lg/ml of 17b-estradiol, 50 lg/ml of
gentamicin, 0.9 mM sodium pyruvate, and 0.1 mM cysteamine). For the
treatment group, 5 lg/ml of CHX were added to the IVM medium. COCs were
incubated in a humidified incubator at 398C and 5% CO
2
in air. After the
treatment period, COCs were washed three times in HEPES-buffered M199 and
once in IVM medium and then matured in the same way as the control group.
Cumulus expansion was assessed by measuring the area of COCs photographed
before and after maturation using the SimplePCI software (Digital Pixel).
Assessment of Nuclear Maturation
Aceto-Orcein staining was carried out to determine the meiotic stages of
oocytes. Cumulus cells were removed, and denuded oocytes were fixed in one
part acetic acid and three parts ethanol for at least 24 h at room temperature.
Fixed oocytes were stained in Aceto-Orcein stain solution (1% orcein and 45%
acetic acid) for 10 min at room temperature. Oocytes were mounted and slides
observed under phase-contrast microscopy at 10003magnification.
IVF, Parthenogenesis, and Somatic Cell Nuclear Transfer
For IVF, a frozen ram semen pellet was thawed and incubated in
capacitation medium (0.33 mM sodium pyruvate, 1.0 mM L-glutamine, 4.0 mM
sodium bicarbonate, 21 mM HEPES, 3.35 mM sodium lactate, 108 mM sodium
chloride, 7.2 mM potassium chloride, 1.2 mM potassium phosphate monobasic,
1.7 mM calcium chloride, 0.49 mM magnesium chloride, 2.4 mM glucose, 0.23
mM phenol red, 50 U/ml of penicillin, and 50 ng/ml of streptomycin; pH 7.4
and 270–290 mOsm) for 1 h at 398C. Motile sperm were collected from the
supernatant, centrifuged at 850 3 g for 10 min at room temperature, and
resuspended in a small volume of IVF medium (2% FBS, 1.0 mM sodium
pyruvate, 1.0 mM L-glutamine, 25 mM sodium bicarbonate, 10 mM sodium
lactate, 108 mM sodium chloride, 7.2 mM potassium chloride, 1.2 mM
potassium phosphate monobasic, 3.4 mM calcium chloride, 0.49 mM
magnesium chloride, 1.4 mM phenol red, 50 U/ml of penicillin, and 50 ng/
ml of streptomycin; pH 7.9 and 270–290 mOsm). Matured COCs were
incubated with 5 000 000 sperm/ml in IVF medium for 20 h in a humidified
incubator at 398C and 5% CO
2
in air. Presumptive zygotes were rinsed and
cultured at 398C with 5% CO
2
and 5% O
2
in synthetic oviduct fluid (SOF; 7.3
mM sodium pyruvate, 0.20 mM L-glutamine, 25 mM sodium bicarbonate, 5.4
mM sodium lactate [syrup], 108 mM sodium chloride, 7.2 mM potassium
chloride, 1.2 mM potassium phosphate monobasic, 1.8 mM calcium chloride,
1.5 mM magnesium chloride, 0.34 mM trisodium citrate, 2.8 mM myo-inositol,
10 lg/ml of phenol red, 0.1 mM essential and nonessential amino acids, and 4
mg/ml of free-fatty-acids bovine serum albumin; pH 7.4 and 270–290 mOsm).
Culture medium was changed at Day 3.
Somatic cell nuclear transfer (SCNT) was carried out as previously described
[27] with minor modifications. Briefly, COCs were denuded of cumulus cells at
14 h postmaturation (hpm) by treatment with hyaluronidase (0.9 mg/ml; Sigma)
combined with repeated, gentle pipetting. Oocytes with extruding spindles at
anaphase I/telophase I (AI/TI) were selected for enucleation. AI/TI oocytes were
briefly incubated in 10 lg/ml of Hoechst 33342 and 7.5 lg/ml of cytochalasin B
(Sigma) in IVM medium, and enucleations were carried out in calcium-free,
HEPES-buffered SOF (hSOF) with 7.5 lg/ml of cytochalasin B using a
micromanipulator. Enucleated oocytes were returned to IVM containing 10 mM
caffeine for 6 h until cell transfer. Fetal fibroblast donor cells were synchronized
in G
0
by serum starvation for at least 2 days before SCNT. One cell was
transferred into the perivitelline space of each enucleated oocyte and fused with
one AC pulse of 1 V for 5 sec and two DC pulses of 100 V for 15 lsec each in
fusion medium (0.3 M mannitol and 0.1 mM magnesium sulfate; 280 mOsm).
Reconstructed embryos were further cultured in IVM medium for 2 h to allow
nuclear envelope breakdown of the donor nucleus. Embryos were then activated
at 25–27 hpm in hSOF containing 5 lM calcium ionophore (A23187) and
calcium ions for 5 min, then rinsed and incubated with 10 lg/ml of CHX and 7.5
lg/ml of cytochalasin B in SOF for 5 h at 398C with 5% CO
2
and 5% O
2
.
Oocytes were then thoroughly rinsed and incubated in SOF.
For parthenogenesis, COCs were denuded from cumulus cells at 24 hpm
and then activated as described for SCNT.
Western Blot Analysis
Oocytes were completely denuded of cumulus cells, thoroughly rinsed in
PBS, and stored at808C in 2 ll of PBS until use. Oocytes were lysed by adding
one volume of 23 Laemmli buffer (Bio-Rad Laboratories) supplemented with
phosphatase inhibitors (5 mM sodium fluoride, 2 mM sodium vanadate, and 2
mM b-glycerophosphate), vortexed, and heated at 958C for 10 min. Samples
were loaded into a denaturing polyacrylamide gel (SDS-PAGE) with lanes of 1.5
mm in width. Protein samples were electrophoresed at 150 V for 70 min, and
resolved proteins were transferred onto a polyvinylidene fluoride membrane
(Bio-Rad Laboratories) at 70 V for 3 h in transfer buffer (25 mM Tris, 192 mM
glycine, and 20% methanol; pH 8.3). After transfer, membranes were blocked in
5% nonfat milk in PBS supplemented with 0.1% Tween 20 (PBS-T) for 1 h at
room temperature, followed by overnight incubation at 48C with primary
antibody rabbit anti-CCNB1 (1:1000; C-8831; Sigma) in blocking buffer. After
several washes in PBS-T, membranes were incubated with secondary antibody
enhanced chemiluminescence (ECL) anti-rabbit immunoglobulin G conjugated
to horseradish peroxidase (HRP; 1:30 000; NA934; Amersham Biosciences, GE
Healthcare) in blocking buffer for 1 h at room temperature. The membrane was
then washed six times for 5 min each time with PBS-T and treated with
Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare).
The chemiluminescence signal was developed with Hyperfilms ECL (Amer-
sham). After washing, membranes were reprobed with rabbit anti-phospho-p44/
42 MAPK antibody (1:2000; 9101; Cell Signaling Technology) in blocking
buffer with a 2-h incubation at room temperature. Following signal detection,
membranes were reprobed for the housekeeping protein a-tubulin using mouse
monoclonal antibody anti-tubulin (1:2000; T5168; Sigma), followed by anti-
mouse secondary antibody conjugated to HRP (1:10 000; SA1-100; Thermo
Scientific) in blocking buffer. For total MAPK, membranes were stripped mildly,
blocked, and incubated with anti-ERK1/2 antibody (1:2000; 9102; Cell Signaling
Technology). Densitometric analysis of blots was carried out with ImageJ
software (National Institutes of Health).
RNA-Ligation Polyadenylation Test
The RNA-ligation polyadenylation assay was used to compare the relative
length of the poly(A) tail as previously described [28]. Briefly, total RNA was
extracted from 30–50 oocytes using the Absolutely RNA Nanoprep kit (Agilent
Technologies) and treated with DNase following the manufacturer’s instructions.
A modified anchor oligo (50-P-GGTCACCTTGATCTGAAGC-NH
2
-30) was
ligated to total RNA followed by cDNA synthesis with SuperScript III Reverse
Transcriptase (Invitrogen) using the PAT-R1 primer (5 0-GCTTCAGAT
CAAGGTGACCTTTTT-30). The QIAGEN Fast Cycling PCR Kit (Qiagen)
was used to amplify target cDNA in 40 cycles of 968C for 10 sec, 628C for 10 sec,
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and 688C for 30 sec using the PAT-R1 reverse primer and the following forward
gene specific primers (5 0 to 3 0): CCNB1, ggctgtggcaaaggtgtaac; MOS,
ctctatgccgtggtggccta; and GDF9 (growth differentiation factor 9), gtcctggccagtg
taaatgc. PCR products were resolved in 1.5%–3% agarose gels prestained with
ethidium bromide.
Quantitative RT-PCR
For gene expression analysis, quantitative RT-PCR (qRT-PCR) was carried
out as previously described [29]. Briefly, total RNA was extracted from oocytes
and converted to cDNA as described above. PCR reactions were performed on
a LightCycler 480 (Roche Diagnostics) using 20-ll reactions containing 10 ll
of FastStart SYBR Green Master Mix (Roche Diagnostics), 300 nM of each
primer, and 1 ll of cDNA template. The thermal cycler program included a
preincubation of 10 min at 958C, followed by 45 cycles at 958C for 20 sec,
628C for 20 sec, and 728C for 20 sec, with single fluorescence acquisition.
Melting curves were performed to ensure gene-specific products. GAPDH was
used as a reference gene for normalization, and relative transcript levels were
calculated by the DDC
T
method. Primer pair sequences were as follows (50 to
30): CCNB1, gattggagaggttgatgttgag and aggtaatgctgtagagttggtg; MOS, gggcaa
catcaccttgcacca and cgctgaccacgtctagggagta; GDF9, attagccttgattctctgccttctag
and gtgtctcccacctaaatggttcag; and GAPDH (glyceraldehyde-3-phosphate dehy-
drogenase), gttccacggcacagtcaagg and actcagcaccagcatcaccc (sequences are
forward and reverse, respectively).
Kinase Assay
TheMPF activity was measured using histone H1 as in vitro substrate. Groups
of 20 oocytes frozen in 5 ll were lysed by three cycles of thawing and freezing on
dry ice. The kinase reaction was started by mixing 5 ll of PBS oocyte lysate with
5 ll of kinase assay buffer (45 mM b-glycerophosphate [pH 7.3], 20 mMMOPS
[3-(N-morpholino)propansulfonic acid], 12 mM MgCl
2
, 12 mM ethyleneglycol-
tetra-acetic acid, 0.1 mM ethylenediaminetetra-acetic acid, 2 mM Na
3
VO
4
, 10
mMNaF, 2 mMdithiothreitol [DTT], 2 mMPMSF, 2 mMbenzamidine, 20 lg/ml
of leupeptin, 20 lg/ml of pepstatin, 20 lg/ml of aprotinin, 1 mg/ml of histone H1,
4 lM protein kinase A-inhibiting peptide [Santa Cruz Biotechnology], 4 lM
protein kinase C-inhibiting peptide [Promega], and 0.5 lCi [34 lM] of
[c-32P]ATP [Amersham Pharmacia Biotech]). The mixtures were incubated at
378C for 45 min. The reaction was stopped by adding 10 ll of ice-cold 23 SDS
sample buffer (125 mM Tris-HCl [pH 6.8], 200 mM DTT, 4% [w/v] SDS, 0.1%
[w/v] bromophenol blue, and 20% [w/v] glycerol). The samples were then boiled
for 4–5 min, and the substrates were separated by SDS-PAGE with 15% gels
using a Mini-PROTEAN II Dual Slab Cell (Bio-Rad Laboratories) at a constant
150 V for 1.5 h. Gels were dried onto 3-mm filters for 1 h at 608C and exposed to
phosphor-screens (Kodak; Amersham Pharmacia Biotech). Kinase activity was
quantified using ImageJ software.
Jasplakinolide and Cytochalasin B Treatments
To stabilize actin filaments during CHX arrest, oocytes were incubated with
5 lg/ml of CHX and 20 lM Jasplakinolide (Jasp; Millipore) in IVM medium.
To destabilize actin filaments during CHX arrest, oocytes were incubated with
5 lg/ml of cytochalasin B and CHX in IVM medium. After treatment, oocytes
were then washed and in vitro matured. All three treatment groups contained
the same concentration of dimethyl sulfoxide (1%), the solvent in which Jasp
was dissolved at a stock concentration of 1 mM.
Statistical Analysis
Student t-test or one-way ANOVA followed by Tukey multiple-comparison
test were carried out for Figure 1 (GraphPad Prism, version 6.00; GraphPad
Software). The differences in the proportions of oocytes undergoing GVBD
after treatments groups were examined by analysis of deviance using
generalized linear models assuming binomial errors and with logit link
functions using GenStat (VSN international, release 11.1). Data are presented
as the predicted back-transformed mean 6 SEM.
RESULTS
Developmental Competence of CHX-Arrested Ovine
Oocytes
Previous studies have reported inconsistent developmental
outcomes of bovine and porcine CHX-treated oocytes [19–
22]. In the present study, we characterized the developmental
competence of CHX-arrested ovine oocytes by investigating
meiotic progression after release, cumulus expansion, and
blastocyst development after parthenogenesis, SCNT, and
IVF.
First, we carried out a dose-response experiment to
determine the minimal CHX concentration required to arrest
ovine oocytes at the GV stage. A CHX concentration of 5 lg/
ml was 95% effective in arresting oocytes at the GV stage and
was therefore chosen for all subsequent experiments (Fig. 1, A
and B). We found that after 24-h CHX arrest, 95% of released
oocytes had undergone GVBD at 3 hpm, whereas in control
oocytes, only 2% had undergone GVBD at 3 hpm (Fig. 1C).
Accelerated GVBD was also observed after release from a
shorter, 6-h arrest period, with 90% of oocytes versus 40% of
controls having undergone GVBD at 5 hpm (P ¼ 0.02) (Fig.
1D). Meiotic acceleration was maintained at 15 hpm, at which
time 87% of oocytes released from CHX arrest had progressed
beyond metaphase I (72% AI and 15% metaphase II [MII])
compared to 35% of nontreated oocytes (33% AI and 2% MII;
P¼ 0.01) (Fig. 1D). By 22 h, nearly all oocytes in both groups
had reached MII (Fig. 1D).
We then asked whether CHX-treated oocytes were develop-
mentally competent. We first investigated the ability of COCs to
undergo cumulus expansion after release from CHX arrest (Fig.
1E) by measuring the area of COCs before and after maturation.
COCs incubated in CHX for 6, 12, and 24 h did not undergo
cumulus expansion before CHX removal. Interestingly, the
length of CHX treatment was inversely correlated with the
capacity of COCs to undergo cumulus expansion after release
from CHX arrest. A reduction of 13%, 30%, and 43% of cumulus
expansion was observed for COCs treated with CHX for 6, 12,
and 24 h, respectively, before IVM for 24 h (Fig. 1F, left).
Nonetheless, all four COC groups reached MII at a high rate as
assessed by polar body extrusion (80–90%) (Fig. 1F, right).
Next, we assessed the effects of CHX treatment on
preimplantation development. We preincubated oocytes with
CHX for 6 or 24 h (nontreated control oocytes were matured
immediately after collection) and, after washing CHX away to
allow maturation, performed parthenogenesis, SCNT, and IVF.
We then assessed developmental competence by measuring
cleavage rates and blastocyst development. After 24 h of CHX
treatment followed by parthenogenesis, we observed a signifi-
cant decrease in cleavage (29/51 vs. 52/52 of control embryos)
and blastocyst formation (12/51 vs. 35/52 of control embryos)
(Fig. 1G). The 24-h treatment with CHX followed by SCNT also
produced reduced cleavage (78/104 vs. 106/112 of control
embryos) and blastocyst formation (10/104 vs. 55/112 of control
embryos) (Fig. 1H). Treatment with CHX for 6 h gave
intermediate results following either parthenogenesis (cleavage
of 41/45 and blastocyst formation of 24/45) or SCNT (cleavage
of 109/121 and blastocyst formation of 39/121) (Fig. 1, G and
H). Following IVF, no significant differences were observed in
cleavage after either 6 or 24 h of CHX treatment compared to
control oocytes, but blastocyst development was reduced in the
24-h CHX group (58/294) compared to the 6-h CHX group
(119/273) and the control group (94/268) (Fig. 1I).
Increased Accumulation of CCNB1 and pMAPK after CHX
Arrest
Germinal vesicle breakdown is accompanied by increases in
CCNB1 synthesis and phosphorylation of MAPK. Therefore,
we hypothesized that increased levels of these proteins
mediated accelerated GVBD in CHX-treated oocytes. We
compared the protein levels of CCNB1 and pMAPK between
control and CHX-treated oocytes. At 6 h after release, we
ACTIN DEPOLYMERIZATION REGULATES GVBD
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observed a 3-fold increase in CCNB1 levels and an 18-fold
increase in pMAPK levels compared to control oocytes
matured for 6 h (Fig. 2). The results also show that changes
in pMAPK are associated with phosphorylation rather than
increased total MAPK levels.
Polyadenylation and Transcription of CCNB1 andMOS Are
Unchanged During CHX Treatment
One possible explanation for the increased translation of
CCNB1 and phosphorylation of MAPK in CHX-treated
FIG. 1. Ovine oocytes released from CHX arrest undergo GVBD acceleration and have lower developmental competence. A) Representative meiotic
stages assessed by Aceto-Orcein staining. B) Meiotic structures observed in oocytes cultured under different CHX concentrations (left) and 40,6-diamidino-
2-phenylindole staining of oocytes at the 0-h culture (control GV) or after 24 h in CHX (right). C) GVBD after 3-h release from CHX (arrested for 24 h)
versus control oocytes at 3 hpm. D) Meiotic progression after 5, 15, and 22 h of maturation of oocytes released from CHX (arrested for 6 h) versus
nontreated oocytes. E) Ovine COCs before maturation (0 hpm) and after 24 h of maturation (same magnification, 3100). F) Cumulus expansion after
meiotic arrest with CHX (6, 12, or 24 h) and released for 24 h. Fold-increase in cumulus expansion (left) as well as polar body extrusion (right) were
determined. G–I) CHX-arrested oocytes (treated for 6 and 24 h) were released after treatment, in vitro matured, and used for parthenogenesis (G), SCNT
(H), or IVF (I). Cleavage was determined after 3 days of development, whereas blastocysts developed from activated/fertilized oocytes (blasts) were
determined at Day 7. Error bars indicate the SD of three independent experiments. The P-values of significantly differing (P , 0.05) groups are presented.
Bar ¼ 20 lm.
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oocytes is that polyadenylation of CCNB1 and MOS is initiated
during CHX treatment. To test this possibility, we carried out
an RL-PAT assay to compare the relative poly(A) tail length of
these mRNAs in oocytes treated with CHX for 24 h. We found
no polyadenylation in these transcripts before release from
CHX arrest (Fig. 3A, lanes 1 and 2) and 3 h after release (Fig.
3A, lanes 3 and4), whereas extensive polyadenylation was
detected in MII oocytes (Fig. 3A, lane 5). GDF9, which in
contrast to CCNB1 and MOS undergoes deadenylation during
oocyte maturation, was also unaffected by CHX treatment (Fig.
3A).
As an alternative mechanism for early accumulation of our
proteins of interest, we asked whether CCNB1 and MOS
mRNA levels increased during CHX treatment. We carried out
qRT-PCR and found no statistically significant differences in
the levels of these transcripts after 24-h CHX arrest and 3 h
after release from arrest (Fig. 3B).
Actin Filament Destabilization During CHX Arrest Is
Associated with Accelerated GVBD after Release
A recent study in zebrafish and mouse oocytes showed that
CCNB1 mRNA is stored in granules associated with actin
filaments, which are released upon oocyte maturation [16]. To
determine if premature release of actin-associated mRNAs
could explain accelerated maturation following CHX treat-
ment, we examined whether interfering with the stability of
actin filaments during CHX arrest also affected GVBD. First,
we assayed different concentrations (2.5, 5, 10, and 20 lM) of
the actin filament-stabilizing agent Jasp in ovine oocytes
treated for 6 h and found that the proportion of oocytes
remaining at the GV stage was dose dependent (0%, 8%,
38%, and 85%, respectively). Then, we stabilized or
destabilized actin filaments during CHX arrest with 20 lM
Jasp or 5 lg/ml of cytochalasin B, respectively. After 6 h of
treatment with CHX and either Jasp or cytochalasin B,
oocytes were thoroughly rinsed and matured for 3 h. GVBD
was delayed in the CHX/Jasp cotreatment group (39%, n ¼
156) compared to the CHX-alone group (66%, n ¼ 168),
whereas it was accelerated in the CHX/cytochalasin B
cotreatment group (80%, n ¼ 156) (Fig. 4A). Treatment of
oocytes with Jasp alone did not prevent resumption of meiosis
(69%, n ¼ 65) (Fig. 4A). We also found that all oocytes
following release from CHX/Jasp could progress beyond
GVBD after 24 h of maturation (not shown), thus confirming
that the GVBD delay in this group was due to actin filament
stabilization and not toxic effects of the treatment. To confirm
FIG. 2. Premature accumulation of CCNB1 and pMAPK in oocytes
released from CHX arrest. A) Protein levels as determined by Western blot
analysis of CCNB1 and pMAPK in 24-h CHX-arrested oocytes (lane 2) and
released oocytes after 6 h of IVM (lane 4) as well as in nontreated control
oocytes before IVM (lane 1) and after 6 h of IVM (lane 3); Matured (24-h)
oocytes were included as positive controls (lane 5). From 80 to 120
oocytes were loaded per lane, and alpha-tubulin was used as a loading
control. B) Densitometric analysis of Western blots at 6 hpm after tubulin
normalization showing relative protein levels of CCNB1 and pMAPK in
oocytes released from CHX arrest versus controls. Error bars indicate the
range of two independent biological replicates.
FIG. 3. Poly(A) tail length and levels of CCNB1,MOS, and GDF9 mRNA
are unchanged in CHX-treated ovine oocytes. A) RL-PAT analysis of
control oocytes matured for 0 h (lane 1), 3 h (lane 3), and 24 h (MII; lane
5) as well as CHX-treated (24-h) oocytes before release (lane 2) or after
release and 3 h of maturation (lane 4). A representative gel of two
biological replicates is shown. Pictures are color-inverted for display
purposes. Sizes are indicated in base pairs; arrows point to polyadenylated
mRNA. B) Relative transcript levels determined by qRT-PCR. Samples
were treated and matured as described in A. Error bars represent the SD of
three biological replicates.
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whether the effect on GVBD of Jasp in CHX-arrested oocytes
was due to an effect on MPF activation, we performed a
histone H1 kinase assay. The results show that MPF activity
increased 1.8-fold in oocytes cultured for 3 h after CHX arrest
compared to those collected after the 6 h of arrest (Fig. 4B).
This increase correlates with the high proportion of GVBD
observed (Fig. 4A). In contrast, oocytes treated with both
CHX and Jasp showed very low levels of MPF activity. MPF
levels in oocytes treated with both CHX and cytochalasin B
were not different from those of the group released from CHX
arrest. Oocytes cultured with Jasp or cytochalasin B alone
showed increases in MPF. Taken together, these functional
assays established an association between actin filament
stability during meiotic arrest, MPF activation, and the
kinetics of GVBD.
DISCUSSION
Our data support the hypothesis that early events normally
associated with meiotic resumption occur during meiotic arrest
with CHX, leading to premature accumulation of meiotic
induction factors and subsequent acceleration of GVBD
following release from arrest. We found that CCNB1 and
pMAPK accumulate earlier in oocytes released from CHX
arrest compared to nontreated oocytes. We showed that such
accumulation is not mediated by polyadenylation or transcrip-
tion of CCNB1 and MOS during CHX arrest. Instead, our data
suggest that stored CCNB1 is released due to actin depoly-
merization during this period, thus facilitating translation of
this ‘‘free’’ mRNA, leading to subsequent GVBD acceleration
in released oocytes.
Because MPF and MAPK activities are key molecules
mediating the kinetics of GVBD, we propose that the earlier
accumulation of CCNB1 and pMAPK in oocytes released from
CHX arrest is associated with GVBD acceleration. We show
that CHX-arrested oocytes undergo a precocious activation of
MPF, which correlates with the accelerated GVBD observed in
this group.
A recent report provided an important insight regarding the
possible mechanisms that might govern accelerated oocyte
maturation after meiotic arrest. Kotani et al. [16] showed that
dormant CCNB1 mRNA forms granules that are associated
with actin filaments and are released during oocyte maturation
in zebrafish. They also found that preventing actin depolymer-
ization with Jasp, which promotes actin filament polymeriza-
tion and stability, prevents CCNB1 RNA granule disassembly,
CCNB1 synthesis, and GVBD in zebrafish oocytes. In contrast,
treatment with cytochalasin B, an actin-depolymerizing agent,
accelerated all of the above processes after induction of
maturation [16]. Based on this, the authors suggested that actin
depolymerization is involved in regulating the timing of
CCNB1 synthesis and meiotic resumption in zebrafish oocytes.
However, their study did not show whether similar events
regulate meiotic resumption in mouse oocytes.
Our data extend these findings to large mammals and
demonstrate a functional association between actin filament
stability before maturation and subsequent kinetics of GVBD
following maturation in ovine oocytes. We found that cotreat-
ment of ovine oocytes with CHX and Jasp for 6 h significantly
delays, but does not prevent, GVBD and reduces MPF
activation following release from arrest compared to the
CHX-alone group. This suggests that initiation of GVBD can
also be triggered by alternative pathways (see below) and that
MPF activation reinforces the process of meiotic progression.
In contrast, cotreatment with CHX and cytochalasin B
accentuated GVBD acceleration following release from these
drugs. These findings in ovine oocytes are consistent with the
role of actin depolymerization in regulating CCNB1 synthesis
and GVBD described in zebrafish [16].
Based on these findings, we propose a model for the
accelerated GVBD phenotype of CHX-treated mammalian
oocytes (Fig. 5). In control oocytes, meiotic resumption
initiates soon after removal from the ovarian follicle and
FIG. 4. Stabilization of actin filaments during CHX arrest prevent
accelerated GVBD after release. A) Percentage of GVBD in oocytes
treated with different compounds and matured for 3 h after release from
CHX arrest. Error bars represent the SEM of four independent biological
replicates. *P , 0.01. B) Histone H1 kinase activity in oocytes treated
under different conditions. Quantification of band intensities is presented
in the histogram. Values represent the fold-differences to the 6-h CHX-
treated group, which was normalized to a value of one.
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results in a gradual release of stored CCNB1 via actin filament
depolymerization (Fig. 5, A and B). CHX-arrested oocytes still
undergo actin filament depolymerization, causing the release of
stored CCNB1, which becomes accessible to the translational
machinery (Fig. 5C). Upon CHX removal, these transcripts are
translated more readily, thus leading to earlier accumulation of
CCNB1, precocious MPF activation, and acceleration of
GVBD (Fig. 5D). In the present study, we also showed that
actin depolymerization plays a role in regulating meiotic
resumption during normal IVM in mammals because treatment
of ovine oocytes with Jasp alone delayed GVBD. However, in
contrast to zebrafish [16], Jasp cannot prevent GVBD in ovine
oocytes, similar to the findings in mouse [30]. This discrepancy
between species suggests that either mammalian oocytes
require a much higher concentration of Jasp to prevent GVBD
or that actin depolymerization plays a more important role in
regulating GVBD in fish.
The mechanism underlying premature MAPK activation
observed in oocytes released from CHX arrest has yet to be
established. One possibility is that stored MOS behaves
similarly to CCNB1, forming granules associated with actin
that are released upon oocyte maturation to allow synthesis of
MOS and activation of the MOS/MEK/MAPK signaling
cascade. Consistent with this is the formation of MOS mRNA
aggregates around the oocyte cortex, a region rich in
ribonucleoproteins in mouse GV oocytes [31]. Furthermore,
FIG. 5. Model of GVBD acceleration in CHX-treated mammalian oocytes. Neither polyadenylation nor transcription of CCNB1 occurs during CHX
arrest or during the onset of maturation. A) A GV oocyte contains CCNB1 mRNA granules associated with intact actin filaments. B) This stored CCNB1
mRNA starts to be released due to actin depolymerization at the onset of maturation. C) During CHX-induced meiotic arrest, depolymerization of actin
filaments still occurs, thus inducing the release of stored CCNB1 transcripts, but CHX inhibits their translation. D) Following CHX removal, the released
stores of CCNB1mRNA facilitate its rapid translation, leading to precocious activation of MPF. MAPK activation is also accelerated, but the mechanism for
this is unclear (see text). The premature activation of MPF and MAPK lead to accelerated GVBD. Counteracting actin depolymerization with Jasp during
CHX arrest reduces the release of stored CCNB1 mRNA and therefore delays the acceleration of GVBD following release from these drugs; the opposite
outcome occurs during cotreatment with the actin depolymerizing agent cytochalasin B, followed by meiotic release.
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increasing the pool of ‘‘free’’ MOS by microinjection of
mRNA into bovine oocytes resulted in maximal MAPK
activation and GVBD acceleration after only 6 h of maturation
[6]. This phenotype is very similar to what we find in oocytes
released from CHX arrest, consistent with the idea that ‘‘free’’
MOS is released from dormant stores during that arrest.
Our data do not support alternative explanations hypothe-
sized for meiotic acceleration, including increased mRNA
polyadenylation or transcription during CHX-induced arrest.
This is consistent with previous reports in progesterone-
stimulated Xenopus oocytes in which no polyadenylation was
observed in the presence of CHX [32, 33]. Therefore, either
protein synthesis, meiotic resumption, or both are necessary for
polyadenylation of dormant mRNA. Interestingly, we found no
increased levels of polyadenylation of CCNB1 or MOS even
after 3 h of release from arrest, demonstrating that polyade-
nylation is not accelerated and therefore cannot be the cause of
increased levels of CCNB1 and pMAPK observed 6 h after
release. Our data also rule out the possibility of increased
transcription resulting in higher levels of CCNB1 and MOS
during CHX arrest because levels of these transcripts remained
unchanged. This was expected as GV oocytes have low
transcriptional activity before meiotic resumption [34, 35].
Some authors have reported chromatin condensation during
CHX arrest [23] and proposed that MPF is partially activated
during this period, thus partly explaining the accelerated
GVBD following CHX release. However, another group failed
to confirm these differences in chromatin configurations
between control and CHX-arrested bovine GV oocytes [24].
Our data support this latter conclusion as we also failed to see
chromatin condensation in either bovine (not shown) or ovine
oocytes arrested with CHX (Fig. 1B).
Although the present study focused primarily on molecular
events within the oocyte, cumulus cells also play a crucial role
in regulating oocyte meiotic resumption. Upon removal of the
COC from the inhibitory follicular environment, MAPK
activation in cumulus cells leads to disruption of gap junction
communications and subsequent decrease of the meiosis-
inhibiting molecule cAMP within the oocyte as cumulus cells
depends on these channels to maintain intraoocyte cAMP
levels (for review, see [4, 36, 37]). It is possible that
phosphorylation of MAPK in cumulus cells could occur during
CHX treatment of COCs, as reported in mice [38]. Therefore,
after CHX arrest, low cAMP levels in the oocyte would
facilitate rapid resumption of meiosis. This additional mech-
anism contributing to meiotic acceleration of CHX-treated
oocytes needs to be fully tested, including whether MAPK
activation in cumulus cells still occurs in the absence of protein
synthesis in large mammals, whether gap junctions are
disrupted if it is, and finally, whether intraoocyte cAMP levels
decrease during treatment. In addition, there could be various
posttranslational modifications in the oocyte and cumulus cells
induced upon removal of the COC from the follicle that are
independent of protein synthesis.
In addition to accelerated meiotic progression, we found that
oocytes released from CHX arrest undergo reduced cumulus
expansion and have lower developmental competence, with all
three phenotypes being accentuated after longer exposure to
CHX. Impaired cumulus expansion has also been observed
after release from MPF inhibitors in bovine oocytes [39]. These
findings suggest that meiotic arrest induced with pharmaco-
logical agents can impair cumulus function. The correlation
found between cumulus expansion and subsequent embryo
development is consistent with previous results in porcine
COCs [40]. Lower development to blastocysts has been
consistently observed in bovine oocytes after 24-h arrest with
CHX [20–22]. However, improved development was reported
after a 12-h CHX treatment in porcine oocytes [18]. This
discrepancy in developmental outcome might be a species-
specific response to CHX. Nonetheless, shorter CHX treat-
ments are compatible with development [20–22] (present
study).
In summary, our findings support a model of actin
depolymerization-mediated release of CCNB1 stores during
CHX arrest, which results in premature accumulation of
CCNB1 and leads to meiotic acceleration following release
from arrest in mammalian oocytes. Accelerated maturation in
released oocytes appears to be caused by early meiotic
resumption during CHX arrest. Thus, we suggest that if
meiotic inhibitors are to be used to improve oocyte quality, it
may be necessary to identify methods that prevent both
accelerated meiotic progression and reduced cumulus expan-
sion, which may compromise the developmental capacity of
these oocytes.
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